CURI financial statements and SEC filings
CURI annual income statement
| Fiscal period end | Revenue | Operating income | Net income | SEC filing |
|---|
| 2025-12-31 | $71.66M | -$7.30M | -$6.43M | 10-K |
| 2024-12-31 | $51.13M | -$13.33M | -$12.94M | 10-K |
| 2023-12-31 | $56.89M | -$44.47M | -$48.90M | 10-K |
| 2022-12-31 | $78.04M | -$55.28M | -$50.92M | 10-K |
| 2021-12-31 | $71.26M | -$52.48M | -$37.63M | 10-K |
| 2020-12-31 | $39.62M | -$38.80M | -$62.39M | 10-K |
CURI annual balance sheet
| Fiscal period end | Assets | Liabilities | Equity | SEC filing |
|---|
| 2025-12-31 | $75.73M | $34.24M | $41.49M | 10-Q |
| 2024-12-31 | $86.18M | $28.33M | $57.85M | 10-K |
| 2023-12-31 | $101.02M | $28.38M | $72.65M | 10-K |
| 2022-12-31 | $154.11M | $36.49M | $117.63M | 10-K |
| 2021-12-31 | $217.58M | $55.64M | $161.94M | 10-K |
| 2020-12-31 | $88.59M | $43.62M | $44.97M | 10-K |
CURI annual cash flow
| Fiscal period end | Operating cash flow | Capital expenditure | Financing cash flow | SEC filing |
|---|
| 2025-12-31 | $13.06M | -$102.00K | -$25.78M | 10-K |
| 2024-12-31 | $8.15M | $0.00 | -$7.01M | 10-K |
| 2023-12-31 | -$16.17M | -$5.00K | -$123.00K | 10-K |
| 2022-12-31 | -$39.52M | -$130.00K | -$218.00K | 10-K |
| 2021-12-31 | -$73.24M | -$351.00K | $148.34M | 10-K |
| 2020-12-31 | -$53.51M | -$367.00K | $36.62M | 10-K |